Type 1 diabetes vs Type 2 diabetes
How to tell Type 1 diabetes and Type 2 diabetes apart when a board question makes them look alike.
Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.
Low C-peptide in a hyperglycemic patient is the fastest discriminator favoring type 1 diabetes.
Side by side
Autoimmune diabetes presents with hyperglycemia, low C-peptide, and pancreatic autoantibodies, requiring insulin from diagnosis.
Type 2 diabetes usually has insulin resistance with preserved or elevated C-peptide and no autoimmune markers.
Immune-mediated beta-cell destruction causes absolute insulin deficiency.
Peripheral insulin resistance and progressive beta-cell dysfunction cause relative insulin deficiency.
Low or undetectable fasting C-peptide, positive GAD65 or IA-2 antibodies, and frequent ketosis support type 1 diabetes.
Normal to high C-peptide early in disease, negative islet antibodies, fasting glucose at or above 126 mg/dL or A1c at or above 6.5 percent support type 2 diabetes.
The trap
A key misstep is assuming adult age excludes type 1 diabetes. The resolving clue is ketosis or rapid weight loss with low C-peptide, which requires immediate insulin rather than delayed oral-only therapy.
The repair move
Next best step: if ketosis or acidosis is present, treat immediately with IV fluids and insulin protocol, then transition to basal-bolus insulin once stable. If hyperglycemia without catabolic features and C-peptide is preserved, initiate lifestyle therapy plus metformin 500 mg once or twice daily and titrate.
Try a free question
CoreA 22-year-old patient has new hyperglycemia, ketonuria, and C-peptide 0.1 ng/mL. What is the next best step in management?
Show answer and explanation
Answer: A. Start insulin-based therapy immediately. Evidence of insulin deficiency with ketosis requires prompt insulin treatment.
Why the other choices are tempting
- B. Metformin alone is inadequate in insulin-deficient catabolic presentation.
- C. Deferring treatment risks DKA progression.
- D. TZD monotherapy does not address acute insulin deficiency.
- E. Lifestyle-only approach is unsafe in this scenario.
Flashcards
Tap a card to flip it.
Which peptide level strongly supports type 1 diabetes in new hyperglycemia?
A low or undetectable C-peptide level.
What laboratory profile is common in early type 2 diabetes?
Preserved or elevated C-peptide with negative islet autoantibodies.
Quick answers
What is the fastest way to tell Type 1 diabetes from Type 2 diabetes?
Low C-peptide in a hyperglycemic patient is the fastest discriminator favoring type 1 diabetes.
What is the key clue for Type 1 diabetes?
Autoimmune diabetes presents with hyperglycemia, low C-peptide, and pancreatic autoantibodies, requiring insulin from diagnosis.
What is the key clue for Type 2 diabetes?
Type 2 diabetes usually has insulin resistance with preserved or elevated C-peptide and no autoimmune markers.
What is the common trap with Type 1 diabetes vs Type 2 diabetes?
A key misstep is assuming adult age excludes type 1 diabetes. The resolving clue is ketosis or rapid weight loss with low C-peptide, which requires immediate insulin rather than delayed oral-only therapy.